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Abstract
A formal [4+3] epoxide cascade protocol utilizing ambiphilic sulfonamides and a variety of epoxides
(masked ambiphiles) has been developed for the generation of benzothiaoxazepine-1,1′-dioxides and
oxathiazepine-1,1′-dioxides. This protocol combines an epoxide ring-opening with either an SNAr
or oxa-Michael cyclization pathway.
The development of cascade reactions, which couple two or more reactions together to produce
heterocyclic scaffolds, is an important challenge in drug discovery and natural product
synthesis.1 Cascade or domino reactions are highly efficient pathways that allow for the
synthesis of complex molecules from simple substrates and encompass a variety of
transformations. Many of these cascade transformations involve the utilization of synthons,
which contain either a nucleophilic or an electrophilic site.2 In contrast, ambiphilic synthons
possess both a nucleophilic and electrophilic site, making them ideal components for cascade
protocols.3,4 Interest in the utilization of cascade reactions for the synthesis of diverse sultam
scaffolds5 has led us to explore the titled protocol where ambiphilic sulfonamides are combined
with an epoxide (a masked ambiphile), are combined in a cascade reaction termed
complementary ambiphile pairing (CAP) (Figure 1).
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Epoxide cascade reactions have been known for over a half-century and have played a key role
in the synthesis of polycyclic natural products.6 Despite the wide application of epoxide
cascade reactions in natural product synthesis, application in the synthesis of complex small
heterocycles has been utilized to a lesser degree. Epoxide cascades can utilize a variety of
organic acids,7 or metal catalysts, to promote the cyclization. These include Au (I) cyclization
with alkynes and allenes,8 SmI2 opening-iodocyclization,9 and cobalt-mediated
cycloadditions.10 Notably absent from the literature are methods which combine epoxide ring-
opening pathways with other pathways in a domino cascade. Towards the realization of this
goal, we herein report the development of a formal [4+3] epoxide cascade protocol which
combines an epoxide ring-opening with either an SNAr or oxa-Michael cyclization pathway
for the generation of benzothiaoxazepine-1,1′-dioxides and oxathiazepine-1,1′-dioxides
(Figure 2).
Reports of the cyclization of an in situ generated epoxide-derived alkoxide via an
intramolecular SNAr cyclization have been limited. Albanese and co-workers first reported the
synthesis of piperazines utilizing an epoxide-opening, SNAr protocol.11 More recently, a key
report by Cleator and co-workers at Merck demonstrated the ring-opening of epoxides with
α-fluorobenzene-sulfonamides, followed by subsequent SNAr cyclization to give the
corresponding piperazines and sultams.12 Reports of intramolecular Michael cyclizations with
vinylsulfonamides have been utilized in seminal work by Knollmüller and Hirooka,13 to more
recent applications in the area of diversity-oriented synthesis (DOS) strategies using a “Click,
Click, Cyclize” approach.14 However, the opening of an epoxide and subsequent cyclization
via oxa-Michael is not known.
Initial investigation into the proposed epoxide cascade focused on the development of
orthogonal reaction conditions that would initiate the ring opening of the corresponding
epoxide, followed by intramolecular SNAr cyclization to yield the desired sultam in a one-pot,
domino process.15 It was found that both the choice of solvent and base was key to the overall
reaction process with dioxane essential for the initial epoxide ring-opening step, and DMF for
the SNAr ring-closing step of the cascade. After screening a wide variety of bases, anhydrous
Cs2CO3 produced the best overall yield and crude purity when utilized in the cascade protocol.
The utilization of microwave irradiation at 110 °C for 20 minutes was essential to obtain both
high yields and crude purity in addition to a significant decrease in reaction times.16,17 After
optimization of reaction conditions for the synthesis of sultam 1, the substrate scope was
investigated using a variety of epoxides and α-fluorobenzenesulfonamides to yield the
corresponding sultams 1–9 in good yield and crude purity (Table 1).18
During these investigations, it was found that when utilizing tert-butyldimethylsilyl (R)-(−)-
glycidyl ether under the aforementioned reactions conditions, the corresponding hydroxy-
sultam 11 was isolated. This presumably occurs when the in situ-generated fluoride ion
deprotects the corresponding TBDMS-protected sultam 10 yielding the free hydroxy sultam
11 in good yield (Table 2).16
With sultam 11 in hand, facile derivatization of the free hydroxy was achieved via ester
formation with a variety of acids. In this case, an oligomer coupling reagent, 2GOACC50,
derived from ring-opening metathesis polymerization (ROMP) was utilized to yield the
corresponding sultam esters 12–16 in high yield and purity without the need for conventional
purification (Table 3).19
We have previously shown that vinylsulfonamides undergo oxa- and aza-Michael additions to
afford the corresponding oxathiazepine-1,1′-dioxides and oxathiazocine-1,1-dioxides.10
Therefore, the utilization of vinylsulfonamides in the aforementioned epoxy cascade reaction
was investigated. In this case, it was envisioned that following the opening of an epoxide with
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a vinylsulfonamide, the in-situ generated hydroxy group would spontaneously undergo a oxa-
Michael cyclization reaction to the corresponding sultam in a one-pot cascade protocol.
The aforementioned SNAr results showed that the utilization of dioxane was essential for
quantitative epoxide opening at 110°C under microwave irradiation. Additionally, the oxa-
Michael cyclization reaction proceeds efficiently in polar solvent such as THF but not DMF.
Using these slightly modified conditions, a variety of vinylsulfonamides were subjected to the
epoxy cascade protocol affording the corresponding sultams 17–24 in good yield and high
crude purity (Table 4).
As demonstrated in the case of α-fluorobenzene sulfonamides (Table 1), the reaction conditions
were tolerant to a variety of vinylsulfonamides and epoxides, allowing for the incorporation
of functional handles and stereogenic centers into the molecule (Table 3, entry 2 and 8). Overall,
the employment of ambiphilic vinylsulfonamides in comparison to α-fluorobenzene
sulfonamides gives rapid access to the corresponding non-benzofused oxathiazepine-1,1′-
dioxide derivatives.
In conclusion, we report the development of a facile, one-pot epoxide cascade protocol for the
synthesis of benzothiaoxazepine-1,1′-dioxides and oxathiazepine-1,1′-dioxides from
ambiphilic sulfonamides. Epoxide ring opening followed by either intramolecular SNAr
cyclization or intramolecular oxa-Michael cyclization yields these heterocycles. In both cases,
a variety of epoxides and sulfonamides were utilized to demonstrate substrate scope and utility
of the method. Ongoing efforts aimed at the investigation of additional CAP strategies continue
and will be reported in due course.
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Generation of sultam hetrocycles utilizing complementary ampbiphile pairing (CAP)
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Epoxide cascade protocols for the synthesis of sultams
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Table 1
One-pot epoxide, SNAr cascade utilizing α-fluorobenzenesulfonamides
entry R1 R2 R3 yield
1 (CH2)3CH3 CH2OBn 6-F 73
2 (CH2)3CH3 (CH2)2CH=CH2 6-F 71
3 4-F-Ph(CH2)2 CH2OPh 6-F 71




6 (CH2)3CH3 CH2OBn 3-Br 65
7 Allyl CH2O(CH2)3CH3 5-Cl 74
8 (CH2)3CH3 CH2OPh 3-Br 78
9 2-OMe-Bn CH2O(CH2)3CH3 5-Cl 74
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Table 2
Proposed mechanism for the generation of Sultam 11
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Table 3
SNAr – intramolecular Mitsunobu route to benzothiaoxazepine-1,1-dioxides
entry R1 yield puritya
1 3-MePh 94 >95%
2 3-OMePh 94 >95%
3 3,4-MePh 96 >95%
4 CH2CN 89 >95%
5 CH2SPh 98 >95%
a
Crude Purity determined by 1H NMR
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Table 4
One-pot epoxy cascade SNAr cyclization utilizing vinylsulfonamides
entry R1 R2 yield
1 Allyl CH2OBn 65
2 Allyl (S)-CH2OBn 63
3 (CH2)3CH3 CH2OBn 58
4 Bn 4-Me-PhOCH2 62
5 Allyl 4-Me-PhOCH2 57
6 Cyclopentyl 4-Me-PhOCH2 55




Org Lett. Author manuscript; available in PMC 2011 March 19.
